Clinical Trials Browser

Nasopharyngeal Carcinoma × famitinib × Clear all

NCT05020925 2021-08-25

SHR-1701 in Combination With Famitinib in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma

Phase 1/2 Unknown

Nasopharyngeal Carcinoma

NCT01392235 2019-01-22

Famitinib in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC)

Phase 2 Completed

Nasopharyngeal Carcinoma